Home   Contact Palatin   Site Map  
 

Investor/Media Center

Investor Materials

    Management bios
     

For Institutional Investors and Media:

Carney Noensie
Burns McClellan
(212) 213-0006
cnoensie@burnsmc.com
 
   
          

Press Releases:

Dec-29-2014 Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
 
Dec-24-2014 Palatin Completes $20 Million Equity and $10 Million Debt Financings
 
Nov-18-2014 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014
 
Nov-13-2014 Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results
 
Oct-08-2014 Palatin Technologies To Present At The 13th Annual Bio Investor Forum
 
Sep-09-2014 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results
 
Sep-04-2014 Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results Teleconference and Webcast to be held on September 9, 2014
 
Sep-03-2014 Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter